GlassScriptPhysician profile
Therlinsie Fleurizard
NPI 1407241664
$27,491.20
in general payments reported to CMS, 2019-2025
14 companies · $85.15 in 2025
The $85.15 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,264 · 2020: $5,117 · 2021: $7,418 · 2022: $2,506 · 2023: $3,015 · 2024: $6,086 · 2025: $85.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,344 · Food and Beverage: $2,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,344.43 |
| Food and Beverage | $2,842.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,116.84 | 2020-2021 | |
| Supreme Orthopedic Systems, LLC | $4,760.64 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $4,666.05 | 2022-2024 | Persona, Rosa, Tapestry |
| Microport Orthopedics INC | $4,208.75 | 2023-2024 | Mpo Medial Pivot Knee |
| Stryker Corporation | $1,691.11 | 2021-2025 | Mako, 1788, Spy-Phi System |
| Encore Medical, LP | $1,300.80 | 2021-2023 | Djo Surgical |
| Abbott Laboratories | $300.13 | 2022 | |
| Medical Device Business Services, INC. | $146.02 | 2021-2022 | |
| Nevro Corp. | $137.16 | 2022 | |
| Medtronic, INC. | $55.56 | 2024 | Interstim |
| Olympus America INC. | $31.64 | 2024 | Olympus, Olympus, Evis Exera III Colonovideoscope |
| Boston Scientific Corporation | $30.56 | 2025 | Axonics |
| Depuy Synthes Sales INC. | $28.60 | 2021 | |
| Ethicon US, LLC | $17.34 | 2023 | Dermabond, Stratafix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Therlinsie Fleurizard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.